Can I read BCG-CWS Adjuvant Therapy in Cancer on EtoBox?

BCG-CWS Adjuvant Therapy in Cancer by Glycation Lab is a document available to read on EtoBox.

What is BCG-CWS Adjuvant Therapy in Cancer about?

This phase 1 study evaluates the safety and immunogenicity of Bacillus Calmette–Guérin cell wall skeleton (BCG-CWS) as an immune adjuvant in patients with advanced WT1-expressing cancers. The recommended dose of BCG-CWS was determined to be 100 μg/body, which was well tolerated and showed promising immune responses and clinical effects. The study highlights the potential of BCG-CWS to enhance cancer immunotherapy by activating the immune system when combined with tumor antigens.

Author

Glycation Lab

Language

EN